Skip to the page

Data / Drug companies / Paroxetine

Paroxetine: 33 companies and 83 products in the FDA NDC directory

Paroxetine is listed in the FDA National Drug Code Directory by 33 companies, with 83 products in commercial distribution. 81 of the products (97.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, film coated, extended release; capsule, and the newest product started marketing on August 21, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
33
Products
83
Generic (ANDA) products
81 (97.6%)
Application numbers
12
Routes
Oral
Brand names
Brisdelle
openFDA record search
api.fda.gov

Companies that list paroxetine

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Chartwell RX, LLC7tablet, film coated; tablet, film coated, extended releaseGeneric drugs (ANDA)November 2, 2021
Remedyrepack Inc.5tablet, film coatedGeneric drugs (ANDA)September 13, 2022
American Health Packaging4tablet, film coatedGeneric drugs (ANDA)March 15, 2005
Asclemed USA, Inc.4tablet, film coatedGeneric drugs (ANDA)April 13, 2007
Aurolife Pharma, LLC4tablet, film coatedGeneric drugs (ANDA)December 3, 2009
Proficient Rx LP4tablet, film coatedGeneric drugs (ANDA)December 3, 2009
Yiling Pharmaceutical, Inc.4tablet, film coatedGeneric drugs (ANDA)November 2, 2021
Zydus Pharmaceuticals USA Inc.4tablet, film coatedGeneric drugs (ANDA)April 13, 2007
Alembic Pharmaceuticals Inc.3tablet, film coated, extended releaseGeneric drugs (ANDA)March 31, 2026
Alembic Pharmaceuticals Limited3tablet, film coated, extended releaseGeneric drugs (ANDA)March 31, 2026
AvPAK3tablet, film coatedGeneric drugs (ANDA)March 11, 2016
Cadila Pharmaceuticals Limited3tablet, film coated, extended releaseGeneric drugs (ANDA)February 14, 2020
Lupin Pharmaceuticals, Inc.3tablet, film coated, extended releaseGeneric drugs (ANDA)March 6, 2017
Modavar Pharmaceuticals LLC3tablet, film coated, extended releaseGeneric drugs (ANDA)October 20, 2021
NCS HealthCare of Ky, LLC DBA Vangard Labs3tablet, film coatedGeneric drugs (ANDA)November 1, 2014
Westminster Pharmaceuticals, LLC3tablet, film coated, extended releaseGeneric drugs (ANDA)July 26, 2021
A-S Medication Solutions2tablet, film coatedGeneric drugs (ANDA)April 13, 2007
Bryant Ranch Prepack2tablet, film coatedGeneric drugs (ANDA)April 13, 2007
Bryant Ranch Prepack2tablet, film coatedGeneric drugs (ANDA)April 13, 2007
Coupler LLC2tablet, film coatedGeneric drugs (ANDA)August 21, 2026
NuCare Pharmaceuticals,Inc.2tablet, film coatedGeneric drugs (ANDA)April 13, 2007
Preferred Pharmaceuticals Inc.2tablet, film coatedGeneric drugs (ANDA)June 6, 2018
Advanced Rx of Tennessee, LLC1tablet, film coatedGeneric drugs (ANDA)May 19, 2023
Ani Pharmaceuticals, Inc.1suspensionGeneric drugs (ANDA)September 3, 2021
Aphena Pharma Solutions - Tennessee, LLC1tablet, film coatedGeneric drugs (ANDA)December 3, 2009
Aphena Pharma Solutions - Tennessee, LLC1tablet, film coatedGeneric drugs (ANDA)December 3, 2009
Direct RX1tablet, film coatedGeneric drugs (ANDA)February 29, 2016
Direct_Rx1tablet, film coatedGeneric drugs (ANDA)June 21, 2023
Hawaii Repack, Inc.1tablet, film coatedGeneric drugs (ANDA)April 13, 2007
Legacy Pharma USA Inc.1capsuleNew drug applications (NDA)February 18, 2025
PD-Rx Pharmaceuticals, Inc.1tablet, film coatedGeneric drugs (ANDA)April 13, 2007
Padagis US LLC1capsuleAuthorized generics (NDA)October 3, 2017
Solco Healthcare US, LLC1capsuleGeneric drugs (ANDA)August 15, 2017

Dosage forms

Dosage formProductsShare
Tablet, film coated5869.9%
Tablet, film coated, extended release2125.3%
Capsule33.6%
Suspension11.2%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)8197.6%
Authorized generics (NDA)11.2%
New drug applications (NDA)11.2%

Pharmacologic classes

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.